The Immunomodulatory Imbalance in Patients with Ketamine Cystitis

Gang-Yi Fan1, Juin-Hong Cherng2, Shu-Jen Chang3

  • 1Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.

Insights

Ketamine cystitis (KC) involves an immune response, with higher IgE, IL-6, and IFN-γ levels and increased T helper cells (TH1, TH2, TH17) observed in patients. This suggests a potential immune mechanism contributing to irreversible bladder damage.

Area of Science:

  • Immunology
  • Urology
  • Pharmacology

Background:

  • Ketamine cystitis (KC) is linked to immune responses, but the exact pathogenesis remains unclear.
  • Understanding the immune mechanisms is crucial for addressing irreversible bladder damage in KC patients.

Purpose of the Study:

  • To propose a potential immune mechanism underlying the irreversible bladder damage in ketamine cystitis (KC).
  • To investigate the roles of specific immune cells and cytokines in KC pathogenesis.

Main Methods:

  • Retrospective assessment of 53 KC patients and 21 healthy controls.
  • Measurement of serum immunoglobulin E (IgE), IL-6, IFN-γ, TGF-β, IL-2, and IL-4 levels.
  • Quantification of T helper cell subsets (TH1, TH2, TH17) and regulatory T cells (TREG).

Main Results:

  • KC patients exhibited significantly elevated serum IgE, IL-6, and IFN-γ compared to controls.
  • KC patients showed significantly higher counts of TH1, TH2, and TH17 cells.
  • Reduced TGF-β levels and comparable IL-2 and IL-4 levels were observed in KC patients.

Conclusions:

  • The immune response in KC may involve IL-6 driven differentiation of TH17 cells, followed by TH1/TH2 alternation.
  • IL-6 may suppress TREG cells, exacerbating chronic inflammation and contributing to KC pathogenesis.
  • Imbalances in TH17 and TREG cells are implicated in KC, warranting further investigation into IL-6's role in related signaling pathways.